isoproterenol has been researched along with triamterene in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fleckenstein, A; Frey, M; Hein, B; Janke, J | 1 |
| Guggenmos, R; Lossnitzer, K; Völger, KD | 1 |
| Fleckenstein, A; Hein, B; Janke, J | 1 |
| Beckmann, CH; Chilton, RJ; Culver, WG; Fournier, DC; Jacobs, RL; Rake, GW | 1 |
| Greeff, K; Noack, EA; Schuhmacher, P | 1 |
1 review(s) available for isoproterenol and triamterene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for isoproterenol and triamterene
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Mechanism of the cardioprotective effect of triamterene in the rat heart. Myocardial protection via elevation of extracellular K+ and Mg++ concentrations].
Topics: Animals; Calcium; Diuresis; Heart; Heart Diseases; Isoproterenol; Magnesium; Male; Myocardium; Potassium; Rats; Triamterene | 1977 |
The influence of triamterene on isoproterenol-induced and spontaneous myocardial calcium uptake in cardiomyopathic hamsters.
Topics: Animals; Calcium; Cricetinae; Female; Heart; Heart Diseases; Isoproterenol; Magnesium; Male; Mesocricetus; Myocardium; Potassium; Time Factors; Triamterene | 1977 |
Proceedings: Restriction of isoproterenol-induced radiocalcium uptake into the ventricular myocardium of rats by triamterene.
Topics: Animals; Biological Transport; Calcium; Calcium Radioisotopes; Heart Ventricles; Isoproterenol; Myocardium; Rats; Triamterene | 1975 |
Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Anaphylaxis; Animals; Blood Pressure; Bradycardia; Dogs; Female; Humans; Isoproterenol; Mice; Middle Aged; Propranolol; Pulse; Triamterene | 1981 |
The effect of triamterene on myocardial phosphodiesterase and adenylate cyclase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Animals; Guinea Pigs; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Triamterene | 1983 |